Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Exp Dermatol. 2021 Nov 26;31(4):615–621. doi: 10.1111/exd.14501

FIGURE 2.

FIGURE 2.

Blocking laminin alpha-3 results in delayed blistering at 72 h. Ex vivo 3D human skin equivalents were treated with laminin alpha-3 blocking antibody (clone: P3H9-2) or vehicle control (n=3/condition). Cultures were harvested for histology at 24 and 72 h, revealing blistering at 72 h, but not 24. Scale bars =50 µm